Bicara Therapeutics Inc. — All Filings
188 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
424B4
424B5
8-A12B
8-K
ARS
CERT
CORRESP
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13G
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | FORM 4 | 0001628280-26-021543 | Mar 26, 2026 | Mar 25, 2026 |
| 144 | — | 0001969223-26-000395 | Mar 25, 2026 | — |
| 4 | FORM 4 | 0001628280-26-020876 | Mar 24, 2026 | Mar 23, 2026 |
| 144 | — | 0001969223-26-000383 | Mar 23, 2026 | — |
| 4 | FORM 4 | 0001628280-26-020236 | Mar 20, 2026 | Mar 18, 2026 |
| 144 | — | 0001969223-26-000379 | Mar 20, 2026 | — |
| 144 | — | 0001969223-26-000375 | Mar 19, 2026 | — |
| 144 | — | 0001969223-26-000370 | Mar 18, 2026 | — |
| 4 | FORM 4 | 0001628280-26-018934 | Mar 17, 2026 | Mar 16, 2026 |
| 144 | — | 0001969223-26-000351 | Mar 16, 2026 | — |
| 4 | FORM 4 | 0001628280-26-016874 | Mar 11, 2026 | Mar 9, 2026 |
| 144 | — | 0001969223-26-000319 | Mar 9, 2026 | — |
| 144 | — | 0001969223-26-000309 | Mar 6, 2026 | — |
| 4 | FORM 4 | 0001628280-26-015778 | Mar 6, 2026 | Mar 4, 2026 |
| 4 | FORM 4 | 0001628280-26-015423 | Mar 5, 2026 | Mar 3, 2026 |
| 144 | — | 0001969223-26-000297 | Mar 5, 2026 | — |
| 4 | FORM 4 | 0001628280-26-015419 | Mar 5, 2026 | Mar 3, 2026 |
| 4 | FORM 4 | 0001628280-26-015421 | Mar 5, 2026 | Mar 3, 2026 |
| 144 | — | 0001969223-26-000280 | Mar 4, 2026 | — |
| 144 | — | 0001969223-26-000282 | Mar 4, 2026 | — |
| 144 | — | 0001969223-26-000283 | Mar 4, 2026 | — |
| 144 | — | 0001969223-26-000272 | Mar 3, 2026 | — |
| 144 | — | 0001969223-26-000275 | Mar 3, 2026 | — |
| 144 | — | 0001969223-26-000274 | Mar 3, 2026 | — |
| SCHEDULE 13D/A | — | 0001346824-26-000066 | Mar 2, 2026 | — |
| 4 | — | 0001231919-26-000231 | Mar 2, 2026 | Feb 26, 2026 |
| 4 | FORM 4 | 0001628280-26-012823 | Feb 27, 2026 | Feb 25, 2026 |
| 424B5 | 424B5 | 0001193125-26-072875 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-076560 | Feb 26, 2026 | Feb 24, 2026 |
| FWP | FWP | 0001193125-26-068187 | Feb 25, 2026 | — |
| 144 | — | 0001969223-26-000230 | Feb 25, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-067160 | Feb 24, 2026 | — |
| 8-K | 8-K | 0001628280-26-009808 | Feb 19, 2026 | — |
| SCHEDULE 13G/A | — | 0000902664-26-001089 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001897612-26-000288 | Feb 17, 2026 | — |
| SCHEDULE 13G | — | 0001172661-26-000689 | Feb 12, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000365 | Feb 5, 2026 | — |
| 4 | FORM 4 | 0001628280-26-005487 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005484 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005474 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005477 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-005479 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | FORM 4 | 0001628280-26-003418 | Jan 26, 2026 | Jan 22, 2026 |
| 4 | FORM 4 | 0001628280-26-003419 | Jan 26, 2026 | Jan 22, 2026 |
| 144 | — | 0001969223-26-000056 | Jan 22, 2026 | — |
| 144 | — | 0001969223-26-000059 | Jan 22, 2026 | — |
| 4 | FORM 4 | 0001628280-26-002656 | Jan 20, 2026 | Jan 15, 2026 |
| 144 | — | 0001969223-26-000047 | Jan 15, 2026 | — |
| 8-K | 8-K | 0001628280-26-001766 | Jan 12, 2026 | — |
| 4 | FORM 4 | 0001628280-25-059045 | Dec 29, 2025 | Dec 26, 2025 |